Amer Bio Medica Stock Earnings Per Share
| ABMCDelisted Stock | USD 0.01 0 38.00% |
Amer Bio Medica fundamentals help investors to digest information that contributes to Amer Bio's financial success or failures. It also enables traders to predict the movement of Amer Pink Sheet. The fundamental analysis module provides a way to measure Amer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amer Bio pink sheet.
Amer |
Amer Bio Medica Company Earnings Per Share Analysis
Amer Bio's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Amer Bio Earnings Per Share | (0.01) X |
Most of Amer Bio's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Bio Medica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Amer Bio Medica has an Earnings Per Share of -0.006 times. This is 100.07% lower than that of the Health Care Equipment & Supplies sector and 100.63% lower than that of the Health Care industry. The earnings per share for all United States stocks is 100.19% higher than that of the company.
Amer Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Bio's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amer Bio could also be used in its relative valuation, which is a method of valuing Amer Bio by comparing valuation metrics of similar companies.Amer Bio is currently under evaluation in earnings per share category among related companies.
Amer Fundamentals
| Return On Asset | -0.42 | ||||
| Profit Margin | (1.13) % | ||||
| Operating Margin | (0.93) % | ||||
| Current Valuation | 2.09 M | ||||
| Shares Outstanding | 48.1 M | ||||
| Shares Owned By Insiders | 31.26 % | ||||
| Number Of Shares Shorted | 5.13 K | ||||
| Price To Earning | (6.72) X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 2.22 M | ||||
| Gross Profit | 548 K | ||||
| EBITDA | (199 K) | ||||
| Net Income | (463 K) | ||||
| Cash And Equivalents | 2 K | ||||
| Total Debt | 1.53 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.25 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | (673 K) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Number Of Employees | 32 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 480.99 K | ||||
| Total Asset | 1.88 M | ||||
| Retained Earnings | (21.24 M) | ||||
| Working Capital | 937 K | ||||
| Current Asset | 2.56 M | ||||
| Current Liabilities | 1.62 M | ||||
| Z Score | -14.4 | ||||
| Net Asset | 1.88 M |
About Amer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amer Bio Medica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amer Bio Medica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amer Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amer Bio's short interest history, or implied volatility extrapolated from Amer Bio options trading.
Pair Trading with Amer Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Bio will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Amer Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amer Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amer Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amer Bio Medica to buy it.
The correlation of Amer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amer Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amer Bio Medica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amer Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |